Matthew Vincent Dolan

Insider Reports History

Entity
Individual
Location
6340 Sequence Dr, San Diego, CA
Signature
By: /s/ Jereme M Sylvain For: Matthew Vincent Dolan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Vincent Dolan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DEXCOM INC EVP Strategy and Corporate Dev Common Stock 40.1K $5.07M $126.58 May 15, 2024 Direct

Insider Reports Filed by Matthew Vincent Dolan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DXCM DEXCOM INC May 15, 2024 1 -$307K 4 May 16, 2024 EVP Strategy and Corporate Dev
DXCM DEXCOM INC Apr 15, 2024 1 -$274K 4 Apr 16, 2024 EVP Strategy and Corporate Dev
DXCM DEXCOM INC Mar 15, 2024 3 -$547K 4 Mar 19, 2024 EVP Strategy & Corp Dev
DXCM DEXCOM INC Mar 12, 2024 1 -$902K 4 Mar 14, 2024 EVP Strategy and Corporate
DXCM DEXCOM INC Mar 8, 2024 1 $0 4 Mar 11, 2024 EVP Strategy and Corporate
DXCM DEXCOM INC Sep 1, 2023 1 -$5.73K 4 Sep 1, 2023 SVP Corporate Strategy-Develop
DXCM DEXCOM INC Mar 16, 2023 1 -$265K 4 Mar 17, 2023 SVP Corporate Strategy-Develop
DXCM DEXCOM INC Mar 10, 2023 5 -$1.35M 4 Mar 14, 2023 SVP Corporate Strategy-Develop
DXCM DEXCOM INC Mar 8, 2023 1 $21.80 4 Mar 10, 2023 SVP Corporate Strategy-Develop
DXCM DEXCOM INC Mar 6, 2023 1 -$25.9K 4 Mar 6, 2023 SVP Corporate Strategy-Develop
DXCM DEXCOM INC Sep 1, 2022 1 -$408 4 Sep 6, 2022 SVP Corporate Strategy-Develop
DXCM DEXCOM INC Mar 15, 2022 3 -$928K 4 Mar 17, 2022 SVP Corporate Development
DXCM DEXCOM INC Mar 8, 2022 5 -$656K 4 Mar 10, 2022 SVP Corporate Development
DXCM DEXCOM INC Mar 4, 2022 0 $0 3 Mar 10, 2022 Officer